IMR Press / CEOG / Volume 43 / Issue 6 / DOI: 10.12891/ceog3189.2016

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report
Successful transvaginal aspiration of interstitial pregnancy after failed methotrexate treatment
Show Less
1 Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei City
2 Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital School of Medicine, Taipei Medical University, Taipei City; 3 Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital School of Medicine, Fu-Jen Catholic University, New Taipei City (Taiwan)
Clin. Exp. Obstet. Gynecol. 2016, 43(6), 899–901; https://doi.org/10.12891/ceog3189.2016
Published: 10 December 2016
Abstract

Interstitial pregnancy is an uncommon condition that is challenging, not only in making an accurate diagnosis, but also in the choice of treatment. Systemic methotrexate (MTX) treatment has been favored to prevent scarring of the uterus. Nevertheless, surgery is generally indicated when this treatment fails. Transvaginal aspiration of the gestational tissue has been proposed as an alternative to surgery. The authors present a case of interstitial pregnancy in which the patient failed to respond to multidose MTX treatment and was successfully treated with transvaginal sonography-guided transvaginal aspiration of the gestational tissue, thereby bypassing the risk associated with undergoing major surgery. Transvaginal aspiration of conceptive tissue may be a novel treatment for patients with unruptured interstitial pregnancy.
Keywords
Transvaginal aspiration
Interstitial pregnancy
Share
Back to top